Preparation of microspheres by the solvent evaporation technique

Advanced Drug Delivery Reviews

Volumn 28, Issue 1, 1997, Pages 25-42

  O'Donnell, Patrick B ^a   McGinity, James W ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Microspheres; Multiple emulsion; Peptides; Proteins; Solvent evaporation; Water soluble compounds

Indexed keywords

EMULSIONS; EVAPORATION; ORGANIC ACIDS; POLYETHERS; PROTEINS; SOLUTIONS;

HYDROXY ACIDS; MICROSPHERES; POLYLACTIC ACID; SOLVENT EVAPORATION;

ENCAPSULATION;

ATRIAL NATRIURETIC FACTOR; BETA GALACTOSIDASE; BOVINE INSULIN; BOVINE SERUM ALBUMIN; CARBONATE DEHYDRATASE; GLYCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INDOMETACIN; MICROSPHERE; PHENOBARBITAL; POLYGLACTIN; POLYLACTIC ACID; SALCATONIN; SOLVENT; SUPEROXIDE DISMUTASE; SURFACTANT; THIORIDAZINE; TUMOR NECROSIS FACTOR; WATER;

BIODEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; EMULSION; EVAPORATION; INTRANASAL DRUG ADMINISTRATION; MICROENCAPSULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SOLUBILITY; SUSTAINED RELEASE PREPARATION; TECHNIQUE; VACCINE PRODUCTION;

EID: 0343683341     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00049-5     Document Type: Review

References (76)

1. Pandey S., Singh U.V., Udupa N. Implantable flurbiprofen for treating inflammation associated with arthritis. Ind. Drugs. 31:1994;254-257.
2. Smith A., Hunneyball I.M. Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration. Int. J. Pharm. 30:1986;215-220.
3. Y.W. Chien, The use of biocompatible polymers in rate-controlled drug delivery systems. Pharm. Tech. May, (1985) 50-66.
4. Chu C.C. Degradation phenonema of two linear aliphatic polyester fibre used in medicine and surgery. Polymerization. 26:1985;591-594.
5. D.H. Lewis, T.R. Tice, G.I. Zatuchni, Polymeric considerations in the design of microencapsulation of contraceptive steroids. Long Acting Contracept. Delivery Syst. (1984) 77-95.
6. Suzuki K., Price J.C. Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly(dl-lactide). J. Pharm. Sci. 74:1985;21-24.
7. Jalil R.U. Biodegradable poly (lactic acid) and poly (lactide-co-glycolide) polymers in sustained drug delivery. Drug Dev. Ind. Pharm. 16:1990;2353-2367.
8. Benoit J.P., Painbeni T., Venier-Julienne M.C. Internal morphology of biodegradable BCNU-loaded microspheres. Proc. Int. Symp. Controlled Release Bioact. Mater. 23rd:1996;379-380.
9. Bodmeier R., McGinity J.W. Solvent selection in the preparation of poly(DL-lactide) microspheres prepared by the solvent evaporation method. Int. J. Pharm. 43:1988;179-186.
10. Bodmeier R., McGinity J.W. Polylactic acid microspheres containing quinidine base and quinidine sulfate prepared by the solvent evaporation method. III. Morphology of the microspheres during dissolution studies. J. Microencapsulation. 5:1988;325-330.
11. Bodmeier R., Wang H., Herrmann J. Microencapsulation of chlorpheniramine maleate, a drug with intermediate solubility properties, by a non-aqueous solvent evaporation technique. STP Pharma. Sci. 4:1994;275-281.
12. Jalil R., Nixon J.R. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J. Microencapsulation. 7:1990;297-325.
13. Bodmeier R., McGinity J.W. The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by the solvent evaporation method. Pharm. Res. 4:1987;465-471.
14. Boisdron-Celle M., Menei P., Benoit J.P. Preparation and characterization of 5-fluorouracil-loaded microparticles as a biodegradable anticancer drug carriers. J. Pharm. Pharmacol. 47:1995;108-114.
15. Verrijk R., Smolders I.J.H., Bosnie N., Begg A.C. Reduction of systemic exposure and toxicity of cisplatin by encapsulation in poly(lactide-co-glycolide). Cancer Res. 52:1992;6653-6656.
16. Mason N., Thies C., Cicero T.J. In vivo and in vitro evaluation of a microencapsulated narcotic antagonist. J. Pharm. Sci. 65:1976;847-850.
17. Yolles S., Leafe T.D., Woodland J.H.R., Meyer F.J. Long acting delivery systems for narcotic antagonists. 2. Release rates of naltrexone from poly(lactic acid) composites. J. Pharm. Sci. 64:1975;348-349.
18. Lalla J.K., Sapna K. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route. J. Microencapsulation. 10:1993;449-460.
19. Cowsar D.R., Tice T.R., Gilley R.M., English J.P. Poly(lactide-co-glycolide) microcapsules for controlled release of steroids. Methods Enzymol. 112:1985;101-116.
20. Giunchedi P., Benvenga A., Alpar H.O., Conte U. PDLLA microspheres containing steroids: Spray-drying and w/o/w emulsification as preparation methods. World Meet. Pharm. Biopharm. Pharm. Technol. 1st:1995;389-390.
21. Beck L.R., Ramos R.A., Flowers C.E., Lopez G.Z., Lewis D.H. Clinical evaluation of injectable biodegradable contraceptive system. Am. J. Obstet. Gynecol. 140:1981;799-806.
22. O'Hern P.A., Goldberg E., Roseman T.J., Peppas N.A., Gabelnick H.L. Development of a contraceptive peptide vaccine for use with PGAL microspheres. Proc. Int. Symp. Controlled Release Bioact. Mater. 20th:1993;394-395.
23. Langer R., Folkman J. Polymers for the sustained release of proteins and other macromolecules. Nature. 263:1976;797-800.
24. Langer R. New methods of drug delivery. Science. 249:1990;1527-1533.
25. Aftabrouchad C., Doelker E. Preparation methods for biodegradable microparticles loaded with water-soluble drugs. STP Pharma. Sci. 2:1992;365-380.
26. P. O'Donnell, B. Schrader, M. Haase, M. Iwata, J.W. McGinity, Multiphase Microspheres of Poly (D,L-Lactic-co-Glycolic Acid) Containing Water-Soluble Compounds, Prepared by a Multiple-Emulsion Solvent Evaporation Technique, in: H.S. Kas, A.A. Hincal (Eds.), Minutes of the 9th Int. Sym. Microencapsulation, Ankara, 1993, pp. 68-75.
27. Maulding H.V., Tice T.R., Cowsar D.R., Fong J.W., Pearson J.E., Nazareno J.P. Biodegradable microspheres: Acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament. J. Control. Release. 3:1986;103-117.
28. Conway B.R., Alpar H.O. Double emulsion microencapsulation of proteins as model antigens using polylactide polymers. Effect of emulsifier on the microsphere characteristics and release kinetics. Eur. J. Pharm. Biopharm. 42:1996;42-48.
29. Jeffery H., Davis S.S., O'Hagan D.T. Preparation and characterization of poly(lactide-co-glycolide) microparticles. Part 2. Entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm. Res. 10:1993;362-368.
30. Herrmann J., Bodmeier R. Effect of particle microstructure on the somatostatin release from poly(lactide) microspheres prepared by a W/O/W solvent evaporation method. J. Control. Release. 36:1995;63-71.
31. Mehta R.C., Thanoo B.C., DeLuca P.P. Peptide containing microspheres from low molecular weight and hydrophilic poly(d,l-lactide-co-glycolide). J. Control. Release. 41:1996;249-257.
32. Sturesson C., Artursson P., Svensson L., Carlfors J. Preparation and characterization of hydrophobic PLG microspheres suitable for oral vaccination with rotavirus. Proc. Int. Symp. Controlled Release Bioact. Mater. 23rd:1996;515-516.
33. Koneberg R., Kissel T. Microencapsulation of tetanus toxoid using poly(lactide-co-glycolide)polymers and novel ABA-triblock-copolymers for single-shot vaccines. World Meet. Pharm. Biopharm. Pharm. Technol. 1st:1995;399-400.
34. Iwata M., McGinity J.W. Preparation of multi-phase microspheres of poly(d,l-lactic acid) and poly(d,l-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique. J. Microencapsulation. 9:1992;201-214.
35. Tabata Y., Gutta S., Langer R. Controlled delivery systems for proteins using polyanhydride microspheres. Pharm. Res. 10:1993;487-496.
36. O'Donnell P.B., Iwata M., McGinity J.W. Properties of Multiphase Microspheres of Poly(D,L-lactic-co-glycolic acid) Prepared by a Potentiometric Dispersion Technique. J. Microencapsulation. 12:1995;155-163.
37. Cavalier M., Benoit J.P., Thies C. The formation and characterization of hydrocortisone-loaded poly((.+-.)-lactide) microspheres. J. Pharm. Pharmacol. 38:1986;249-253.
38. Uchida T., Yoshida K., Ninomiya A., Goto S. Optimization of preparative conditions for polylactide (PLA) microspheres containing ovalbumin. Chem. Pharm. Bull. 43:1995;1569-1573.
39. Bodmeier R., Oh K.H., Chen H. Effect of the addition of low molecular weight poly(dl-lactide) on drug release from biodegradable poly(dl-lactide) drug delivery systems. Int. J. Pharm. 51:1989;1-8.
40. Sato T., Kanke M., Schroeder H.G., DeLuca P.P. Porous biodegradable microspheres for controlled drug delivery. Part 1. Assessment of processing conditions and solvent removal techniques. Pharm. Res. 5:1988;21-30.
41. Sansdrap P., Moes A.J. Influence of manufacturing parameters on the size characteristics and the release profiles of nifedipine from poly(DL-lactide-co-glycolide) microspheres. Int. J. Pharm. 98:1993;157-164.
42. Li W.-I., Anderson K.W., DeLuca P.P. Kinetic and thermodynamic modeling of the formation of polymeric microspheres using solvent extraction/evaporation method. J. Control. Release. 37:1995;187-198.
43. Conti B., Genta I., Modena T., Pavanetto F. Investigation on process parameters involved in polylactide-co-glycolide microspheres preparation. Drug Dev. Ind. Pharm. 21:1995;615-622.
44. Izumikawa S., Yoshioka S., Aso Y., Takeda Y. Preparation of poly(l-lactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release rate. J. Control. Release. 15:1991;133-140.
45. Jalil R., Nixon J.R. Microencapsulation using poly(DL-lactic acid) III: Effect of polymer molecular weight on the release kinetics. J. Microencapsulation. 7:1990;357-374.
46. The United States Pharmacopoeia, 23 revision, (1995) Organic Volitile Impurities. Rockville, USA, pp. 1747.
47. Bitz C., Doelker E. Influence of the preparation method on residual solvents in biodegradable microspheres. World Meet. Pharm. Biopharm. Pharm. Technol. 1st:1995;409-410.
48. Gangrade N., Price J.C. Simple gas chromatographic headspace analysis of residual organic solvent in microspheres. J. Pharm. Sci. 81:1992;201-202.
49. Sturesson C., Carlfors J., Edsman K., Andersson M. Preparation of biodegradable poly(lactic-co-glycolic) acid microspheres and their in vitro release of timolol maleate. Int. J. Pharm. 89:1993;235-244.
50. Bodmeier R., McGinity J.W. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. II. Some process parameters influencing the preparation and properties of microspheres. J. Microencapsulation. 4:1987;289-297.
51. Spenlehauer G., Vert M., Benoit J.P., Chabot F., Veillard M. Biodegradable cisplatin microspheres prepared by the solvent evaporation method: morphology and release characteristics. J Controlled Release. 7:1988;217-229.
52. Wang H.T., Schmitt E., Flanagan D.R., Linhardt R.J. Influence of formulation methods on the in vitro controlled release of protein from poly(ester) microspheres. J. Control. Release. 17:1991;23-31.
53. Pradhan R.S., Vasavada R.C. Formulation and in vitro release study on poly(DL-lactide) microspheres containing hydrophilic compounds: glycine homopeptides. J. Control. Release. 30:1994;143-154.
54. Herrmann J., Bodmeier R. Somatostatin containing biodegradable microspheres prepared by a modified solvent evaporation method based on w/o/w-multiple emulsions. Int. J. Pharm. 126:1995;129-138.
55. Schugens C., Laruelle N., Nihant N., Jerome R., Teyssie P.et al. Effect of the emulsion stability on the morphology and porosity of semicrystalline poly l-lactide microparticles prepared by w/o/w double emulsion-evaporation. J. Control. Release. 32:1994;161-176.
56. Soriano I., Delgado A., Diaz R.V., Evora C. Use of surfactants in polylactic acid protein microspheres. Drug Dev. Ind. Pharm. 21:1995;549-558.
57. Lu W., Park T.G. Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems. PDA J. Pharm. Sci. Technol. 49:1995;13-19.
58. Cohen S., Yoshioka T., Lucarelli M., Hwang L.H., Langer R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res. 8:1991;713-720.
59. Crotts G., Park T.G. Preparation of porous and nonporous biodegradable polymeric hollow microspheres. J. Control. Release. 35:1995;91-105.
60. Sah H.K., Toddywala R., Chien Y.W. Influence of biodegradable microcapsule formulations on the controlled release of a protein. J. Control. Release. 30:1994;201-211.
61. O'Hagan D.T., Rahman D., Jeffery H., Sharif S., Challacombe S.J. Controlled release microparticles for oral immunization. Int J Pharm. 108:1994;133-139.
62. Sah H., Toddywala R., Chien Y.W. Continuous release of proteins from biodegradable microcapsules and in vivo evaluation of their potential as a vaccine adjuvant. J. Control. Release. 35:1995;137-144.
63. O'Hagen D.T., McGee J.P., Boyle R., Gumaer D., Koff W.C.et al. Preparation, characterization and pre-clinical evaluation of an orally administered HIV-1 vaccine, consisting of a branched peptide immunogen entrapped in controlled release microparticles. J. Control. Release. 36:1995;75-84.
64. Alpar H.O., Almeida A.J. Identification of some of the physico-chemical characteristics of microspheres which influence the induction of the immune response following mucosal delivery. Eur. J. Pharm. and Biopharm. 40:1994;198-202.
65. Makino K., Ohshima H., Kondo T. Effects of plasma proteins on degradation properties of poly(L-lactide) microcapsules. Pharm Res. 4:1987;62-65.
66. Makino K., Ohshima H., Kondo T. Mechanism of hydrolytic degradation of poly(L-lactide) microcapsules: effects of pH, ionic strength and buffer concentration. J. Microencapsulation. 3:1986;203-212.
67. Frisbee S.E., McGinity J.W. Influence of nonionic surfactants on the physical and chemical properties of a biodegradable pseudolatex. Eur. J. Pharm. and Biopharm. 40:1994;355-363.
68. O'Donnell P.B., McGinity J.W. Properties of Multiphase microspheres of poly(dl-lactic acid) or poly(dl-lactic-co-glycolic acid) produced by mechanical agitation, sonication, or potentiometric dispersion. J. Microencapsulation. 13:1996;667-677.
69. Liu L.S., D'Emanuele A., Langer R. Experimental approach to elucidate the mechanism of ultrasound enhanced polymer erosion and release of incorporated substances. Macromolecules. 25:1992;123-128.
70. G. Reich, Ultrasound induced degradation of aliphatic polyesters during microsphere processing: influence of formulation variables, in: Proceedings of 1st World Meeting on Pharm. Biopharm. and Pharm. Tech., Budapest, 1995, pp. 9-11.
71. Sah H.K., Chien Y.W. Evaluation of a microreservoir-type biodegradable microcapsule for controlled release of proteins. Drug Dev. Ind. Pharm. 19:1993;1243-1263.
72. Hayashi Y., Yoshioka S., Aso Y., Li Wan Po A., Terao T. Entrapment of proteins in poly(L-lactide) microspheres using reversed micelle solvent evaporation. Pharm. Res. 11:1994;337-340.
73. Brange J., Langkjaer L., Havelund S., Volund A. Chemical Stability of Insulin. 1. Hydrolytic Degradation During Storage of Pharmaceutical Preparations. Pharm. Res. 9:1992;715-726.
74. Uchida T., Yagi A., Oda Y., Nakada Y., Goto S. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. Chem. Pharm. Bull. 44:1996;235-236.
75. Park T.G., Lu W., Crotts G. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(DL-lactic acid-co-glycolic acid) microspheres. J. Control. Release. 33:1995;211-222.
76. Johnson R.E., Lanaski L.A., Gupta V., Griffin M.J., Gaud H.T., Needham T.E., Zia H. Stability of atriopeptin III in poly(DL-lactide-co-glycolide) microspheres. J. Control. Release. 17:1991;61-67.